1 Aug 2026Open access
Design, Synthesis, and Antibiofilm Efficacy of Ag/Se‐Doped CuO–Chitosan Nanocomposites as Potent Antifungal Agents Against Candida albicansPublisher siteChemistry & Biodiversity, Nanoparticles: synthesis and applications
UniversitiesAhmed A. Al‐Karmalawy
Active, last published 2026
In synthesis and biological activity
Ahmed A.
Al‐Karmalawy
Scholar“Research focused on Synthesis and biological activity and adjacent fields.”
Horus University – Egypt
Claim Your Profile54
H-index
7.9k
Citations
Ahmed has not officially claimed their profile. If you are Ahmed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
hmed A. Al‐Karmalawy is a researcher working on Synthesis and biological activity. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ahmed's work has been cited 7,917 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Synthesis and biological activity×72Computational Drug Discovery Methods×41Cancer therapeutics and mechanisms×34Synthesis and Biological Evaluation×28SARS-CoV-2 and COVID-19 Research×19
04 · Where I am
Affiliations
Affiliation on published researchHorus University – EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
72 works22 Apr 2026Open access
Integrated metabolite profiling and molecular docking reveal anti-aging potential of Clerodendrum infortunatum L. fractionsPublisher siteScientific Reports, Phytochemistry and Biological Activities
19 Apr 2026Open access
Antiviral activity and chemical characterization of Egyptian Ziziphus spina-christi against human respiratory virusesPublisher siteScientific Reports, Ziziphus Jujuba Studies and Applications
1 Apr 2026
Targeting the Menin– <i>KMT2A</i> Interface: Medicinal Chemistry Rules Governing Reversible, Covalent, and Degrader InhibitorsPublisher siteChemical Biology & Drug Design, Microtubule and mitosis dynamics
29 Mar 2026
PTC‐Assisted Chemoselective <i>S</i> ‐Alkylation of 5‐Mercapto‐1,3,4‐Oxadiazol Derivative: Multi‐Target Anticancer via EGFR, Telomerase, and Thymidylate Synthase Inhibition With Apoptosis InductionPublisher siteDrug Development Research, Synthesis and biological activity
4 Nov 20251cites
Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insightsPublisher siteBioorganic Chemistry, Phosphodiesterase function and regulation
1 Jul 20253cites
Targeting AMPK with ivabradine attenuates cyclophosphamide-induced hepatotoxicity: Crosstalk with MAPK, JAK1/STAT3, and PI3K/Akt pathwaysPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Chemotherapy-induced organ toxicity mitigation
28 Jun 2025Open access2cites
Cytotoxic and proapoptotic effects of alizarin in mice with Ehrlich solid tumor: novel insights into ERα-mediated MDM2/p-Rb/E2F1 signaling pathwayPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Cancer-related Molecular Pathways
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ahmed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you